Skip to main content
Print Save

Lidocaine ophthalmic Pregnancy and Breastfeeding Warnings

Lidocaine ophthalmic is also known as: Akten

Lidocaine ophthalmic Pregnancy Warnings

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus.

US FDA pregnancy category: B

Animal studies have failed to reveal evidence of fetal harm when given subcutaneously at doses up to 50 mg/kg. There are no controlled data in human pregnancy.

US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

See references

Lidocaine ophthalmic Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Yes

Comments:
-Systemic exposure is not expected.
-The effects in the nursing infant are unknown.

See references

See also

References for pregnancy information

  1. "Product Information. Akten (lidocaine ophthalmic)." Akorn Inc (2008):

References for breastfeeding information

  1. "Product Information. Akten (lidocaine ophthalmic)." Akorn Inc (2008):
  2. United States National Library of Medicine "Toxnet. Toxicology Data Network. http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT" (2013):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer